The global insect growth regulators (IGRs) market is expected to reach USD
1.23 billion by 2025, according to a new report by Grand View Research, Inc.
Globally increasing consumption of environment friendly pesticides has been a
major factor driving market growth. In addition, growing adoption of organic farming
techniques has led to the increased utilization of insect growth
regulators.
IGRs
are considered as a safer alternative to insecticides. These are non-toxic in
nature and degrade rapidly. They also do not contaminate the groundwater and
soil. The application of IGRs does not lead to harmful effects on advantageous
soil microbes, animals, and humans. Numerous advantages of IGRs, such as lesser
harmful impact on the environment and enhanced compatibility with pest
management practices, make them attractive alternatives to several
insecticides.
Juvenile
hormone analogs and mimics were the fastest growing product category in 2016
and is expected to maintain a substantial growth rate over the forecast period.
Chitin synthesis inhibitors was the major IGR consumed with a share of over 42%
in 2016.
Commercial
applications are expected to observe the fastest growth over the next eight
years with an estimated CAGR of around 6.7% from 2016 to 2025. Commercial
applications of IGRs include government pest control programs at public places,
commercial office buildings, schools, hospitals, and aircrafts. Agriculture
applications dominated the overall market in 2016. Farmers are adopting safer
alternatives of harmful insecticides for application in farmlands and livestock.
Moreover, increasing prevalence of organic farming and integrated pest
management are posing huge demand towards demand of IGRs insect growth
regulators in the global market.
Access Research Report of Insect Growth Regulators
Market@ http://www.grandviewresearch.com/industry-analysis/insect-growth-regulators-market
Further key findings
from the report suggest:
· The
global insect growth regulators revenue generated USD 723.3 million in 2016 and
is expected to grow at a CAGR of 6.2% from 2017 to 2025
· Chitin
synthesis inhibitors emerged as the largest product segment in 2016
· Global
IGRs revenue from agriculture application is anticipated to witness staggered
growth over the next eight years
· The
industry in Asia Pacific is projected to witness substantial growth over the
next decade owing to various developments across major economies, especially in
the agricultural industry.
· Key
players including Bayer AG, Central Life Science, OHP, Inc., Syngenta AG, Dow
AgroSciences LLC, Helm Agro US, Inc., Nufarm Limited, Russell IPM, Valent USA
LLC
Grand
View Research has segmented the global insect growth regulators market on the
basis of product, form, application and region:
Insect Growth Regulators Product Outlook
(Revenue, USD Million, 2014 - 2025)
·
Chitin
synthesis inhibitors
·
Juvenile
hormone analogs and mimics
·
Ecdysone
Antagonists
·
Ecdysone
Agonists
Insect Growth Regulators Form Outlook
(Revenue, USD Million, 2014 - 2025)
·
Aerosol
·
Liquid
·
Bait
Insect Growth Regulators Application
Outlook (Revenue, USD Million, 2014 - 2025)
·
Agriculture
·
Residential
·
Commercial
Insect Growth Regulators Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North
America
o U.S.
·
Europe
o Italy
o France
·
Asia
Pacific
o China
o Australia
·
Central
& South America
o Brazil
·
Middle East &
Africa
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment